ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS

被引：0
|
作者：
Rovida, E. [1 ]
Navari, N. [1 ]
Cannito, S. [2 ]
Dello Sbarba, P. [1 ]
Parola, M. [2 ]
Marra, F. [1 ]
机构：
[1] Univ Florence, Florence, Italy
[2] Univ Turin, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60893-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [1] ERK5 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA (HCC), AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS
    Rovida, E.
    Navari, N.
    Cannito, S.
    Dello Sbarba, P.
    Parola, M.
    Marra, F.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S42 - S42
  • [2] ERK5 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA (HCC), AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS
    Terzi, E.
    Piscaglia, F.
    Trimarchi, C.
    Golfieri, R.
    Giampalma, M.
    Cappelli, A.
    Renzulli, M.
    Gramantieri, L.
    Pini, P.
    Serio, I.
    Bolondi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S42 - S43
  • [3] Liver transplantation for hepatocellular carcinoma (HCC): Predictive factors of HCC recurrence, an interim analysis
    Gianni, S
    Mirante, V
    Fassati, LR
    Forti, D
    Mazzaferro, V
    Cillo, U
    Maffei, A
    Grazi, G
    Salizzoni, M
    Filipponi, F
    Valente, U
    Castagneto, M
    Tisone, G
    Bresadola, F
    Pompili, M
    Farinati, F
    Naccarato, R
    Gasbarrini, G
    GASTROENTEROLOGY, 2003, 124 (04) : A708 - A708
  • [4] C-REL AND P27KIP ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO
    Di Maira, G.
    Rovida, E.
    Navari, N.
    Cannito, S.
    Dello Sbarba, P.
    Parola, M.
    Marra, F.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E37 - E38
  • [5] c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO
    Di Maira, G.
    Rovida, E.
    Navari, N.
    Cannito, S.
    Della Sbarba, P.
    Parola, M.
    Marra, F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S97 - S98
  • [6] Prognostic factors associated with liver transplantation (LT) for hepatocellular carcinoma (HCC)
    Duvoux, C
    Traissac, L
    Roudot-Thoraval, F
    Vandelemmens, C
    Conti, F
    Pageaux, G
    Cherqui, D
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 48 - 48
  • [7] Evaluation of prognostic factors in hepatocellular carcinoma (HCC) treated with orthotopic liver transplantation (OLT).
    Netto, G
    Goldstein, R
    Do, K
    Stone, M
    Husberg, B
    Levy, M
    Jennings, L
    Tran, M
    Klintmalm, G
    MODERN PATHOLOGY, 1998, 11 (01) : 155A - 155A
  • [8] HUMAN-ALBUMIN SYNTHESIS IN LIVER SLICES AND HEPATOCELLULAR CARCINOMA CELLS (HCC) IN CULTURE
    WEIGAND, K
    ALPERT, E
    ISSELBACHER, KJ
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1977, 358 (10): : 1295 - 1295
  • [9] Prognostic factors affecting 1-year hepatocellular carcinoma (HCC) progression in liver transplantation candidates
    Luca, M. G.
    Vezzoli, S.
    Armellini, E.
    De Giorgio, M.
    Bezzo, R.
    Gaffuri, G.
    Nani, R.
    Colledan, M.
    Fagiuoli, S.
    Strazzabosco, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A46 - A47
  • [10] High Dose Hypofractionated Intensity Modulated Radiation Therapy (HH-IMRT) in Hepatocellular Carcinoma (HCC) in Cirrhotic Liver
    Moorthy, Chitti
    Facciuto, Marcello
    Shih, Lynn
    Rocchio, Ronald
    Chitti, Ramana
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 211 - 211
12345